FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         	UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  	OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5	
                      	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	                      	

1. Name and Address of Reporting Person *

Hagerman Philip R	2. Issuer Name and Ticker or Trading Symbol

Diplomat Pharmacy, Inc. [ DPLO ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Chairman and CEO	
(Last)          (First)          (Middle)

4100 S. SAGINAW STREET	3. Date of Earliest Transaction (MM/DD/YYYY)

4/19/2017		
(Street)

FLINT, MI 48507
(City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)

 	6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person	

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned	
1.Title of Security
(Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code
(Instr. 8)	4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)	5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)	
			Code	V	Amount	(A) or (D)	Price				
Common Stock  	4/19/2017  	 	A	  	7519   (1)	A	$0  	7519  	D  	 	
Common Stock  	 	 	 	  	 	 	 	1499756  	I  	Philip R. Hagerman Revocable Trust   (2)	
Common Stock  	 	 	 	  	 	 	 	3891609  	I  	2007 Hagerman Family GST   (3)	
Common Stock  	 	 	 	  	 	 	 	4450091  	I  	The JH GST Trust   (2)	
Common Stock  	 	 	 	  	 	 	 	1550876  	I  	2013 Irrev. Exempt Trust for Daughter   (3)	
Common Stock  	 	 	 	  	 	 	 	1550876  	I  	2013 Irrev. Exempt Trust for Son   (3)	
Common Stock  	 	 	 	  	 	 	 	1215293  	I  	2013 Irrev. Exempt Trust for Daughter   (2)	
Common Stock  	 	 	 	  	 	 	 	1371292  	I  	2013 Irrev. Exempt Trust for Daughter   (2)	
Common Stock  	 	 	 	  	 	 	 	313337  	I  	2014 Irrev. Exempt Trust for Son   (3)	
Common Stock  	 	 	 	  	 	 	 	313337  	I  	2014 Irrev. Exempt Trust for Daughter   (3)	
Common Stock  	 	 	 	  	 	 	 	313337  	I  	2014 Irrev. Exempt Trust for Daughter   (2)	
Common Stock  	 	 	 	  	 	 	 	313337  	I  	2014 Irrev. Exempt Trust for Daughter   (2)	
Common Stock  	 	 	 	  	 	 	 	696659  	I  	Jocelyn Hagerman Living Trust   (3)	
Common Stock  	 	 	 	  	 	 	 	301212  	I  	Philip R. Hagerman Living Trust   (2)	
Common Stock  	 	 	 	  	 	 	 	263500  	I  	JH Marital Trust   (2)	
Common Stock  	 	 	 	  	 	 	 	272000  	I  	PH Marital Trust   (3)	
Common Stock  	 	 	 	  	 	 	 	394910  	I  	Irrevocable Trust for Son  	
Common Stock  	 	 	 	  	 	 	 	394910  	I  	Irrevocable Trust for Daughter  	
Common Stock  	 	 	 	  	 	 	 	367256  	I  	Irrevocable Non-Exempt Trust for Son  	
Common Stock  	 	 	 	  	 	 	 	367256  	I  	Irrevocable Non-Exempt Trust for Daughter  	

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)	
1. Title of Derivate Security
(Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code
(Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)	6. Date Exercisable and Expiration Date	7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)	8. Price of Derivative Security
(Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)	
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares					

Explanation of Responses:	
(1) 	The restricted stock units ("RSUs") were granted in connection with the Issuer's equity incentive plan. The RSUs will vest on the third anniversary of the grant date.	
(2) 	These shares are indirectly owned by Mr. Hagerman as the trustee of the Philip R. Hagerman Revocable Trust, the Philip R. Hagerman Living Trust, The JH GST Trust, the 2013 Irrevocable Exempt Trusts and 2014 Irrevocable Exempt Trusts for two daughters, and the JH Marital Trust.	
(3) 	Jocelyn Hagerman is Mr. Hagerman's wife. These shares are indirectly owned by her as a trustee of the 2007 Hagerman Family GST Trust, the 2013 Irrevocable Exempt Trusts and 2014 Irrevocable Exempt Trusts for a son and daughter, the Jocelyn Hagerman Living Trust, and the PH Marital Trust.	

Reporting Owners	
Reporting Owner Name / Address	Relationships	
	Director	10% Owner	Officer	Other	
Hagerman Philip R
4100 S. SAGINAW STREET
FLINT, MI 48507	X	X	Chairman and CEO		

Signatures		
Jeffrey H. Kuras, by Power of Attorney		6/5/2017	
** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.	
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).	
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).	
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.	
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.